These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 28635766)

  • 21. Comparison of the Pharmacological Effects of Dimeric Dipeptide Nerve Growth Factor Mimetic GK-2 and Mexidol on the Model of Ischemic Stroke in Rats.
    Povarnina PY; Volkova AA; Gudasheva TA; Seredenin SB
    Bull Exp Biol Med; 2017 Dec; 164(2):173-176. PubMed ID: 29181667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combining Neuroprotection With Endovascular Treatment of Acute Stroke: Is There Hope?
    Tymianski M
    Stroke; 2017 Jun; 48(6):1700-1705. PubMed ID: 28487331
    [No Abstract]   [Full Text] [Related]  

  • 23. Time for a neurorestorative therapy in stroke.
    Jäkälä P; Jolkkonen J
    Expert Opin Biol Ther; 2012 Mar; 12(3):267-70. PubMed ID: 22251201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [To modify the design of preclinical trials: a lesson from the failure of neuroprotection trials in stroke].
    Li YS
    Zhonghua Nei Ke Za Zhi; 2010 Sep; 49(9):733-4. PubMed ID: 21092440
    [No Abstract]   [Full Text] [Related]  

  • 25. Challenges of neuroprotection and neurorestoration in ischemic stroke treatment.
    Martínez-Vila E; Irimia P
    Cerebrovasc Dis; 2005; 20 Suppl 2():148-58. PubMed ID: 16327266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of neuroprotectors in patients with tension headaches.
    Medvedeva LA; Gnezdilov AV; Zagorul'ko OI; Syrovegin AV; Samoilova NV
    Neurosci Behav Physiol; 2007 Jun; 37(5):523-6. PubMed ID: 17505806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroprotection as initial therapy in acute stroke. Third Report of an Ad Hoc Consensus Group Meeting. The European Ad Hoc Consensus Group.
    Cerebrovasc Dis; 1998; 8(1):59-72. PubMed ID: 9645985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biotherapies in stroke.
    Detante O; Jaillard A; Moisan A; Barbieux M; Favre IM; Garambois K; Hommel M; Remy C
    Rev Neurol (Paris); 2014 Dec; 170(12):779-98. PubMed ID: 25459115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroprotection in the Treatment of Acute Ischemic Stroke.
    Patel RAG; McMullen PW
    Prog Cardiovasc Dis; 2017; 59(6):542-548. PubMed ID: 28465001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in stroke neuroprotection: hyperoxia and beyond.
    Singhal AB; Lo EH; Dalkara T; Moskowitz MA
    Neuroimaging Clin N Am; 2005 Aug; 15(3):697-720, xii-xiii. PubMed ID: 16360598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacological neuroprotection against brain damage in ischemiai/reperfusion experiment].
    Petrov VI; Ponomarev ÉA; Maskin SS; Strepetov NN
    Eksp Klin Farmakol; 2011; 74(8):13-6. PubMed ID: 22232908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroprotection for ischemic stroke: two decades of success and failure.
    Cheng YD; Al-Khoury L; Zivin JA
    NeuroRx; 2004 Jan; 1(1):36-45. PubMed ID: 15717006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroprotection and stroke.
    Mostardini C; Vicenzini E; Altieri M; Di Stani F; Lenzi D; Di Piero V
    Cerebrovasc Dis; 2000; 10 Suppl 4():21-3. PubMed ID: 11070395
    [No Abstract]   [Full Text] [Related]  

  • 34. New approaches to neuroprotective drug development.
    Fisher M
    Stroke; 2011 Jan; 42(1 Suppl):S24-7. PubMed ID: 21164111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Neurometabolic therapy in secondary prevention of stroke].
    Koval'chuk VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(3):24-8. PubMed ID: 24781222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [An analysis of mexidol efficacy in the complex treatment of patients with ischemic stroke].
    Lutskiĭ MA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(4 Suppl 2):57-9. PubMed ID: 20740717
    [No Abstract]   [Full Text] [Related]  

  • 37. Can molecular and cellular neuroprotection be translated into therapies for patients?: yes, but not the way we tried it before.
    Tymianski M
    Stroke; 2010 Oct; 41(10 Suppl):S87-90. PubMed ID: 20876514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of phenyl-tert-butylnitrone, mexidol and nooglutil on the ischemic lesion zone and memory in rats following middle cerebral artery occlusion].
    Povarova OV; Garibova TL; Kalenikova EI; Galaeva IP; Kraĭneva VA; Medvedev OS; Voronina TA
    Eksp Klin Farmakol; 2004; 67(1):3-6. PubMed ID: 15079898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stroke therapy strategy change: how to achieve neuroprotection.
    Braun JS
    Int J Stroke; 2010 Jun; 5(3):234. PubMed ID: 20536621
    [No Abstract]   [Full Text] [Related]  

  • 40. Role of neuroprotective drugs in acute ischemic stroke.
    Venti M; Parnetti L; Silvestrelli G; Gallai V
    Cerebrovasc Dis; 2000; 10 Suppl 4():24-6. PubMed ID: 11070396
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.